BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology (NASDAQ:CLVS) today announced that two oral presentations and six poster sessions highlighting updated results and trial designs from clinical studies of the company’s three compounds in advanced clinical development are being presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29-June 2, 2015 in Chicago.
Help employers find you! Check out all the jobs and post your resume.
